ArticleNature2018
Fundamental limits to graphene plasmonics.
Article in Nature, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 106 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
106 citing papers in PubMed.
- Electrically programmable polariton symmetry breaking via non-Hermitian dissipation engineering.Nature materials · 2026Article
- Anisotropic strong coupling between two propagating polariton modes.Nature communications · 2026Article
- Enhanced Terahertz Photoresponse via Acoustic Plasmon Cavity Resonances in Scalable Graphene.ACS photonics · 2026Article
- Mid-infrared long-range surface polaritons in two-dimensional van der Waals materials.Science advances · 2026Article
- Cavity-Defined van der Waals Plasmonic Nanolasers Enabled by Out-Of-Plane Dipole Coupling.Advanced materials (Deerfield Beach, Fla.) · 2026Article
- Plasmon Engineering in Intercalated 2H-TaSNano letters · 2026Article
- Low-temperature hyperbolic phonon polaritonics with suppressed phononic scattering.Science advances · 2026Article
- Infrared Near-Field Microscopy as a Platform for Nanoscale Biomedical Spectroscopy and Imaging.ACS applied materials & interfaces · 2026Review
- Long-Range Polariton Canalization in a Graphene-Nanoribbon-Covered MgTeMoONanophotonics (Berlin, Germany) · 2026Article
- Dirac Surface-State Driven Broad Spectral Band Low Quantum Energy Photoresponse in Quaternary Topological BiSbSeAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Fundamentals of Deep-Subwavelength Near-Field Imaging With Hyperbolic Polaritons.Nanophotonics (Berlin, Germany) · 2026Article
- Resonant Dyakonov-Shur Magnetoplasmons in Graphene Terahertz Photodetectors.Nanophotonics (Berlin, Germany) · 2026Article
- Phonon engineering enables hyperbolic asymptotic line polaritons.Nature nanotechnology · 2026Article
- Fundamental optical phenomena of strongly anisotropic polaritons at the nanoscale.Nature nanotechnology · 2026Review
- Transverse-Electric Cherenkov Radiation for TeV-Scale Particle Detection.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Ultimate tuning of hyperbolic phonon polaritons.Science advances · 2025Article
- Orthogonal canalized polaritons via coupling graphene plasmon and phonon polaritons of hBN metasurface.Nanophotonics (Berlin, Germany) · 2025Article
- Engineering super- and sub-radiant hybrid plasmons in a tunable graphene frame-heptamer metasurface.Nanophotonics (Berlin, Germany) · 2025Article
- Observation of hyperbolic intersubband polaritons in native-dielectric-doped van der Waals semiconductor quantum wells.Nature communications · 2025Article
- Polaritonic quantum matter.Nanophotonics (Berlin, Germany) · 2025Review
46 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Plasmon polaritons are hybrid excitations of light and mobile electrons that can confine the energy of long-wavelength radiation at the nanoscale. Plasmon polaritons may enable many enigmatic quantum effects, including lasing
Identifiers
29795255What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.